RedHill Biopharma Ltd. logo

RedHill Biopharma Ltd.

RDHL | NASDAQ
Chart Builder DCF Calculator
$0.55
$0 (+0.02%)
At close: Sep 22, 2026, 3:59 PM ET
$0.54
-$0.01 (-1.65%)
After-hours: Sep 22, 2026, 7:18 PM ET

Market Data

Market Cap
$1.73M
Enterprise Value
$-1.17M
Beta
4.95
Average Volume
163.55K
Shares Outstanding (Diluted)
1.8M
Shares Change YoY
-23.34%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US7574683014

Price Performance

Price Change 1M
-12.7%
Price Change 3M
-40.6%
Price Change 6M
-38.2%
Price Change YTD
-46.6%
Price Change 1Y
-67.1%
Price Change 3Y
-97.0%
Price Change 5Y
-100.0%
1M CAGR (ann.)
-9.1%
1Y CAGR (ann.)
-67.7%
5Y CAGR (ann.)
-85.1%
All-Time CAGR
-51.5%

Valuation

PE Ratio
-0.14
Forward PE
N/A
PEG Ratio
-0.00
Forward PEG
0.00
PS Ratio
0.18
Forward PS
N/A
PB Ratio
0.40
P/FCF Ratio
-0.21
P/Adj. FCF Ratio
-0.19
P/OCF Ratio
-0.20
EV/Sales
-0.12
EV/EBIT
0.14
EV/EBITDA
0.15
EV/FCF
0.14
Earnings Yield
-727.3%
FCF Yield
-475.1%
Adj. FCF Yield
-517.5%

Financial Health

Net Cash
$3.97M
Total Debt
$1.07M
Cash & Short-Term Investments
$3.97M
Total Assets
$25.35M
Current Ratio
0.34
Quick Ratio
0.34
Debt / Equity Ratio
0.25
Debt / EBITDA
-0.14
Debt / FCF
-0.13
OCF / Debt
-7.66
Interest Coverage
-4.28
Altman Z-Score
-24.10
Piotroski F-Score
5

Margins & Profitability

Gross Profit Margin
60.6%
Operating Profit Margin
-110.4%
EBITDA Margin
-103.2%
Net Profit Margin
-101.3%
FCF Margin
-86.0%
Adj. FCF Margin
-93.7%
SBC / Revenue
7.3%
SBC Impact (per share)
-8.9%

Returns

Return on Assets
-16.3%
Return on Equity
5740.3%
Return on Invested Capital
-69.6%
Return on Capital Employed
-71.5%
Return on Tangible Assets
-20.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
-49.7%
Revenue CAGR 5Y
-17.5%
Revenue CAGR 10Y
105.8%
EPS CAGR 3Y
65.0%
EPS CAGR 5Y
74.5%
EPS CAGR 10Y
19.0%
FCF CAGR 3Y
46.1%
FCF CAGR 5Y
36.5%
FCF CAGR 10Y
4.2%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Mar 17, 2027
EPS Estimate (next Q)
-$433.33
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
$24.09M
Revenue Growth Est (next Q)
1081.0%

Cash Flow

Operating Cash Flow
$-8.2M
Free Cash Flow
$-8.21M
Adj. Free Cash Flow
$-8.94M
FCF Per Share
-$2.78
OCF Per Share
-$2.78
OCF/S Ratio
-122.9%

Income Statement

Revenue
$9.55M
Gross Profit
$6.16M
Operating Income
$-10.54M
EBITDA
$-7.91M
Net Income
$-9.31M
EPS (Diluted)
-$4
Revenue / Employee
$734.62K
Profit / Employee
$-716.38K
Employees
13

© 2026 bestshares.com. All rights reserved.